Earlier this week, Dianthus Therapeutics completed an upsized follow-on offering raising about US$625.00 million in common stock and pre-funded warrants, shortly after reporting wider 2025 losses and ...
The MarketWatch News Department was not involved in the creation of this content. Inc.'s annual Female Founders list celebrates the nation's most innovative women entrepreneurs, who collectively ...